Xenical (orlistat) / GSK, Roche  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xenical (orlistat) / Roche, GSK
T1HLP, NCT02767531: Orlistat for the Treatment of Type I Hyperlipoproteinemia

Completed
2
2
US
Orlistat, Alli
University of Texas Southwestern Medical Center
Hyperlipoproteinemia Type I, Hypertriglyceridemia
05/18
12/22
NCT05816343: Long Term Efficacy and Safety of Orlistat for Type 1 Hyperlipoproteinemia

Recruiting
2
28
US
Orlistat, Alli, Placebo
University of Texas Southwestern Medical Center
Type 1 Hyperlipoprotenemia
04/25
07/25

Download Options